Disentangling the link between maternal influences on birth weight and disease risk in 36,211 genotyped mother–child pairs
Epidemiological studies have robustly linked lower birth weight to later-life disease risks. These observations may reflect the adverse impact of intrauterine growth restriction on a child's health. However, causal evidence supporting such a mechanism in humans is largely lacking. Using Mendeli...
Main Authors: | , , |
---|---|
Other Authors: | , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Springer
2024
|
Subjects: | |
Online Access: | http://hdl.handle.net/10138/572183 |
id |
ftunivhelsihelda:oai:helda.helsinki.fi:10138/572183 |
---|---|
record_format |
openpolar |
institution |
Open Polar |
collection |
HELDA – University of Helsinki Open Repository |
op_collection_id |
ftunivhelsihelda |
language |
English |
topic |
Gynaecology and paediatrics Coronary-heart-disease Mendelian randomization Fetal origins Association Inference Born Life |
spellingShingle |
Gynaecology and paediatrics Coronary-heart-disease Mendelian randomization Fetal origins Association Inference Born Life Leinonen, Jaakko T. Pirinen, Matti Tukiainen, Taru Disentangling the link between maternal influences on birth weight and disease risk in 36,211 genotyped mother–child pairs |
topic_facet |
Gynaecology and paediatrics Coronary-heart-disease Mendelian randomization Fetal origins Association Inference Born Life |
description |
Epidemiological studies have robustly linked lower birth weight to later-life disease risks. These observations may reflect the adverse impact of intrauterine growth restriction on a child's health. However, causal evidence supporting such a mechanism in humans is largely lacking. Using Mendelian Randomization and 36,211 genotyped mother-child pairs from the FinnGen study, we assessed the relationship between intrauterine growth and five common health outcomes (coronary heart disease (CHD), hypertension, statin use, type 2 diabetes and cancer). We proxied intrauterine growth with polygenic scores for maternal effects on birth weight and took into account the transmission of genetic variants between a mother and a child in the analyses. We find limited evidence for contribution of normal variation in maternally influenced intrauterine growth on later-life disease. Instead, we find support for genetic pleiotropy in the fetal genome linking birth weight to CHD and hypertension. Our study illustrates the opportunities that data from genotyped parent-child pairs from a population-based biobank provides for addressing causality of maternal influences.A Mendelian Randomization study with 36,211 mother-child pairs indicates that maternal genetic variants, influencing a child's birth weight, impact the child's risk for common diseases through inheritance and not by effects on intrauterine growth. Peer reviewed |
author2 |
Genomics of Sex Differences Institute for Molecular Medicine Finland Helsinki Institute of Life Science HiLIFE Centre of Excellence in Complex Disease Genetics Helsinki Institute for Information Technology Statistical and population genetics Department of Mathematics and Statistics Department of Public Health Molecular and Integrative Biosciences Research Programme |
format |
Article in Journal/Newspaper |
author |
Leinonen, Jaakko T. Pirinen, Matti Tukiainen, Taru |
author_facet |
Leinonen, Jaakko T. Pirinen, Matti Tukiainen, Taru |
author_sort |
Leinonen, Jaakko T. |
title |
Disentangling the link between maternal influences on birth weight and disease risk in 36,211 genotyped mother–child pairs |
title_short |
Disentangling the link between maternal influences on birth weight and disease risk in 36,211 genotyped mother–child pairs |
title_full |
Disentangling the link between maternal influences on birth weight and disease risk in 36,211 genotyped mother–child pairs |
title_fullStr |
Disentangling the link between maternal influences on birth weight and disease risk in 36,211 genotyped mother–child pairs |
title_full_unstemmed |
Disentangling the link between maternal influences on birth weight and disease risk in 36,211 genotyped mother–child pairs |
title_sort |
disentangling the link between maternal influences on birth weight and disease risk in 36,211 genotyped mother–child pairs |
publisher |
Springer |
publishDate |
2024 |
url |
http://hdl.handle.net/10138/572183 |
genre |
Arctic |
genre_facet |
Arctic |
op_relation |
10.1038/s42003-024-05872-9 We thank all FinnGen participants, principal investigators, laboratory personnel and data management teams. The FinnGen project is funded by two grants from Business Finland (HUS 4685/31/2016 and UH 4386/31/2016) and the following industry partners: AbbVie Inc., AstraZeneca UK Ltd, Biogen MA Inc., Bristol Myers Squibb (and Celgene Corporation & Celgene International II Sarl), Genentech Inc., Merck Sharp & Dohme LCC, Pfizer Inc., GlaxoSmithKline Intellectual Property Development Ltd., Sanofi US Services Inc., Maze Therapeutics Inc., Janssen Biotech Inc, Novartis AG, and Boehringer Ingelheim International GmbH. Following biobanks are acknowledged for delivering biobank samples to FinnGen: Auria Biobank (www.auria.fi/biopankki), THL Biobank (www.thl.fi/biobank), Helsinki Biobank (www.helsinginbiopankki.fi), Biobank Borealis of Northern Finland (https://www.ppshp.fi/Tutkimus-ja-opetus/Biopankki/Pages/Biobank-Borealis-briefly-in-English.aspx), Finnish Clinical Biobank Tampere (www.tays.fi/en-US/Research_and_development/Finnish_Clinical_Biobank_Tampere), Biobank of Eastern Finland (www.ita-suomenbiopankki.fi/en), Central Finland Biobank (www.ksshp.fi/fi-FI/Potilaalle/Biopankki), Finnish Red Cross Blood Service Biobank (www.veripalvelu.fi/verenluovutus/biopankkitoiminta), Terveystalo Biobank (www.terveystalo.com/fi/Yritystietoa/Terveystalo-Biopankki/Biopankki/) and Arctic Biobank (https://www.oulu.fi/en/university/faculties-and-units/faculty-medicine/northern-finland-birth-cohorts-and-arctic-biobank). All Finnish Biobanks are members of BBMRI.fi infrastructure (www.bbmri.fi). Finnish Biobank Cooperative -FINBB (https://finbb.fi/) is the coordinator of BBMRI-ERIC operations in Finland. The Finnish biobank data can be accessed through the Fingenious (R) services (https://site.fingenious.fi/en/) managed by FINBB. T.T. was funded by Sigrid Juselius Foundation (https://sigridjuselius.fi/en/), the HiLIFE Fellows Program, and the Research Council of Finland (grant number 315589). M.P. was supported by the Research Council of Finland (https://www.aka.fi/en/) grant 338507, Research Council of Finland Center of Excellence in Complex Disease Genetics grant 352795, and the Sigrid Juselius Foundation. Open access funded by Helsinki University Library. Leinonen , J T , Pirinen , M & Tukiainen , T 2024 , ' Disentangling the link between maternal influences on birth weight and disease risk in 36,211 genotyped mother–child pairs ' , Communications Biology , vol. 7 , no. 1 , 175 . https://doi.org/10.1038/s42003-024-05872-9 ORCID: /0000-0002-1664-1350/work/154560939 ORCID: /0000-0001-7530-6918/work/160779523 http://hdl.handle.net/10138/572183 a4aab6ca-58e6-432c-b9a1-cd44fe899ae9 38347176 85185101462 001161487300004 |
op_rights |
cc_by info:eu-repo/semantics/openAccess openAccess |
_version_ |
1802639107084517376 |
spelling |
ftunivhelsihelda:oai:helda.helsinki.fi:10138/572183 2024-06-23T07:48:47+00:00 Disentangling the link between maternal influences on birth weight and disease risk in 36,211 genotyped mother–child pairs Leinonen, Jaakko T. Pirinen, Matti Tukiainen, Taru Genomics of Sex Differences Institute for Molecular Medicine Finland Helsinki Institute of Life Science HiLIFE Centre of Excellence in Complex Disease Genetics Helsinki Institute for Information Technology Statistical and population genetics Department of Mathematics and Statistics Department of Public Health Molecular and Integrative Biosciences Research Programme 2024-03-01T07:49:05Z 9 application/pdf http://hdl.handle.net/10138/572183 eng eng Springer 10.1038/s42003-024-05872-9 We thank all FinnGen participants, principal investigators, laboratory personnel and data management teams. The FinnGen project is funded by two grants from Business Finland (HUS 4685/31/2016 and UH 4386/31/2016) and the following industry partners: AbbVie Inc., AstraZeneca UK Ltd, Biogen MA Inc., Bristol Myers Squibb (and Celgene Corporation & Celgene International II Sarl), Genentech Inc., Merck Sharp & Dohme LCC, Pfizer Inc., GlaxoSmithKline Intellectual Property Development Ltd., Sanofi US Services Inc., Maze Therapeutics Inc., Janssen Biotech Inc, Novartis AG, and Boehringer Ingelheim International GmbH. Following biobanks are acknowledged for delivering biobank samples to FinnGen: Auria Biobank (www.auria.fi/biopankki), THL Biobank (www.thl.fi/biobank), Helsinki Biobank (www.helsinginbiopankki.fi), Biobank Borealis of Northern Finland (https://www.ppshp.fi/Tutkimus-ja-opetus/Biopankki/Pages/Biobank-Borealis-briefly-in-English.aspx), Finnish Clinical Biobank Tampere (www.tays.fi/en-US/Research_and_development/Finnish_Clinical_Biobank_Tampere), Biobank of Eastern Finland (www.ita-suomenbiopankki.fi/en), Central Finland Biobank (www.ksshp.fi/fi-FI/Potilaalle/Biopankki), Finnish Red Cross Blood Service Biobank (www.veripalvelu.fi/verenluovutus/biopankkitoiminta), Terveystalo Biobank (www.terveystalo.com/fi/Yritystietoa/Terveystalo-Biopankki/Biopankki/) and Arctic Biobank (https://www.oulu.fi/en/university/faculties-and-units/faculty-medicine/northern-finland-birth-cohorts-and-arctic-biobank). All Finnish Biobanks are members of BBMRI.fi infrastructure (www.bbmri.fi). Finnish Biobank Cooperative -FINBB (https://finbb.fi/) is the coordinator of BBMRI-ERIC operations in Finland. The Finnish biobank data can be accessed through the Fingenious (R) services (https://site.fingenious.fi/en/) managed by FINBB. T.T. was funded by Sigrid Juselius Foundation (https://sigridjuselius.fi/en/), the HiLIFE Fellows Program, and the Research Council of Finland (grant number 315589). M.P. was supported by the Research Council of Finland (https://www.aka.fi/en/) grant 338507, Research Council of Finland Center of Excellence in Complex Disease Genetics grant 352795, and the Sigrid Juselius Foundation. Open access funded by Helsinki University Library. Leinonen , J T , Pirinen , M & Tukiainen , T 2024 , ' Disentangling the link between maternal influences on birth weight and disease risk in 36,211 genotyped mother–child pairs ' , Communications Biology , vol. 7 , no. 1 , 175 . https://doi.org/10.1038/s42003-024-05872-9 ORCID: /0000-0002-1664-1350/work/154560939 ORCID: /0000-0001-7530-6918/work/160779523 http://hdl.handle.net/10138/572183 a4aab6ca-58e6-432c-b9a1-cd44fe899ae9 38347176 85185101462 001161487300004 cc_by info:eu-repo/semantics/openAccess openAccess Gynaecology and paediatrics Coronary-heart-disease Mendelian randomization Fetal origins Association Inference Born Life Article publishedVersion 2024 ftunivhelsihelda 2024-06-04T14:34:43Z Epidemiological studies have robustly linked lower birth weight to later-life disease risks. These observations may reflect the adverse impact of intrauterine growth restriction on a child's health. However, causal evidence supporting such a mechanism in humans is largely lacking. Using Mendelian Randomization and 36,211 genotyped mother-child pairs from the FinnGen study, we assessed the relationship between intrauterine growth and five common health outcomes (coronary heart disease (CHD), hypertension, statin use, type 2 diabetes and cancer). We proxied intrauterine growth with polygenic scores for maternal effects on birth weight and took into account the transmission of genetic variants between a mother and a child in the analyses. We find limited evidence for contribution of normal variation in maternally influenced intrauterine growth on later-life disease. Instead, we find support for genetic pleiotropy in the fetal genome linking birth weight to CHD and hypertension. Our study illustrates the opportunities that data from genotyped parent-child pairs from a population-based biobank provides for addressing causality of maternal influences.A Mendelian Randomization study with 36,211 mother-child pairs indicates that maternal genetic variants, influencing a child's birth weight, impact the child's risk for common diseases through inheritance and not by effects on intrauterine growth. Peer reviewed Article in Journal/Newspaper Arctic HELDA – University of Helsinki Open Repository |